← Open Payments lookup

MARIE KAUFMANN: Open Payments

NPI 1447805510 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,142 in 93 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,369 · 2025 $2,142

Food & beverage: $2,142
CompanyPaymentsAmount
PFIZER INC.14$311
Novo Nordisk Inc12$267
ABBVIE INC.11$212
AstraZeneca Pharmaceuticals LP9$212
Gilead Sciences, Inc.8$205
ViiV Healthcare Company5$129
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$110
Amgen Inc.4$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$80
Takeda Pharmaceuticals U.S.A., Inc.3$72

Products named: NURTEC ODT, APRETUDE, CAPLYTA, PREVNAR 20, AIRSUPRA, Wegovy, Ozempic, FARXIGA.

Industry payments across VA — which companies pay providers there.